Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sopharma Trading ADXBUL:SFT 82 Days Payable is 49.58 as of Mar. 2026, which is 29% above its 10-year median of 38.52. GuruFocus rates XBUL:SFT with a GF Score™ of 82/100 and a GF Value™ of €7.67 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 115 Medical Distribution companies, Sopharma Trading AD ranks worse than 80% on this metric.
The historical rank and industry rank for Sopharma Trading AD's Days Payable or its related term are showing as below:
XBUL:SFT'
s Days Payable Range Over the Past 10 Years
Min: 32.08 Med: 38.52 Max: 47.94
Current: 47.94
During the past 13 years, Sopharma Trading AD's highest Days Payable was 47.94. The lowest was 32.08. And the median was 38.52.
XBUL:SFT's Days Payable is ranked worse than 80% of 115
companies
in the Medical Distribution industry
Industry Median: 79.11
vs XBUL:SFT: 47.94
Sopharma Trading AD's Days Payable
increased
from Mar. 2025 (46.92) to Mar. 2026 (49.58).
It may suggest that Sopharma Trading ADdelayed paying its suppliers.
Sopharma Trading AD Days Payable Related Terms
Sopharma Trading AD Days Payable Historical Data
* Premium members only.
The historical data trend for Sopharma Trading AD's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XBUL:SFT vs MCK, CAH, COR: Days Payable Comparison
For the Medical Distribution subindustry, Sopharma Trading AD's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sopharma Trading AD Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sopharma Trading AD's Days Payable distribution charts can be found below:
* The bar in red indicates where Sopharma Trading AD's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Sopharma Trading AD's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sopharma Trading AD (XBUL:SFT) has a Days Payable of 49.58 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sopharma Trading AD and its competitors. This is 29% above median its historical median of 38.52. Over the past decade, Sopharma Trading AD's Days Payable has ranged from 32.08 to 47.94. According to the industry distribution chart, Sopharma Trading AD ranks #92 out of 115 companies in the Medical Distribution industry, placing it in the top 80%.
Is Sopharma Trading AD's Days Payable too high?
Sopharma Trading AD's current Days Payable of 49.58 is 29% above median its 10-year median of 38.52. Over the past 10 years, this metric has ranged from a low of 32.08 to a high of 47.94. The Medical Distribution industry median Days Payable is 79.11. Sopharma Trading AD's value of 49.58 is 37.3% below this industry median. Based on the distribution chart, Sopharma Trading AD ranks #92 out of 115 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Sopharma Trading AD has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sopharma Trading AD's Days Payable compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Sopharma Trading AD ranks #92 out of 115 companies for Days Payable. This places Sopharma Trading AD in the lower half of its industry. The industry median Days Payable is 79.11. Sopharma Trading AD's value of 49.58 is 37.3% below this benchmark. Historically, Sopharma Trading AD's own Days Payable has ranged from 32.08 to 47.94 over the past decade. While the company's 10-year median is 38.52 vs. the industry median of 79.11, Sopharma Trading AD has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 79.11, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sopharma Trading AD's current Days Payable of 49.58 is 37.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sopharma Trading AD and its competitors. For the Medical Distribution industry, the median Days Payable is 79.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sopharma Trading AD's current Days Payable is 49.58, which is 29% above median its own 10-year median of 38.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sopharma Trading AD stock overvalued right now?
Based on GuruFocus' analysis, Sopharma Trading AD (XBUL:SFT) is currently considered Significantly Undervalued. The stock's GF Value™ is €7.67, compared to a current price of €2.86 — trading 62.7% below its estimated fair value. The current Days Payable is 49.58, which is 29% above median its 10-year median of 38.52 and 37.3% below the Medical Distribution industry median of 79.11. Sopharma Trading AD's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Sopharma Trading AD (XBUL:SFT), the current Days Payable is 49.58 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sopharma Trading AD (XBUL:SFT) Overvalued in 2026?
Based on GuruFocus' analysis, Sopharma Trading AD stock appears to be undervalued.
The current stock price of €2.86 is trading 62.7% below its estimated GF Value™ of €7.67.
GuruFocus considers Sopharma Trading AD to be Significantly Undervalued.
Key valuation signals for XBUL:SFT:
Days Payable: 49.58 (29% above median its 10-year median of 38.52)
GF Value™: €7.67 vs. price of €2.86 (62.7% below fair value)
Industry Position: 37.3% below the Medical Distribution median (#92 of 115)
No single metric tells the full story. See the XBUL:SFT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.
82GF Score
Get the complete analysis for XBUL:SFT
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XBUL:SFT has been successfully added to your 
